Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
2021
2014
Americas
Clear all
Type of publications
NITAG documentation
(66)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Americas
(70)
Africa
(17)
Europe
(83)
South-East Asia
(2)
Western Pacific
(16)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(18)
Chile
(9)
United States of America
(40)
Diseases
COVID-19
(64)
Meningococcal disease
(6)
Diphtheria
(1)
Ebola
(1)
Haemophilus influenzae type B
(1)
Hepatitis A
(1)
Human papillomavirus (HPV)
(14)
Influenza
(9)
Pertussis
(3)
Pneumococcal disease
(3)
Rotavirus
(2)
Typhoid
(1)
Varicella
(1)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(2)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2021
(65)
2014
(5)
2024
(2)
2023
(12)
2022
(45)
2020
(63)
2019
(6)
2018
(3)
2017
(1)
2016
(9)
2015
(5)
2013
(3)
2011
(3)
2010
(1)
2009
(1)
2008
(1)
2007
(2)
2006
(3)
2005
(1)
1997
(1)
70 results found
2021
∙
NACI
Recommendations on the use of COVID-19 Vaccines
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2014
∙
NACI
Advice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine
2014
∙
Jessica MacNeil
Epidemiology of Serogroup B Meningococcal Disease
2014
∙
NACI
Literature review on serogroup B invasive meningococcal disease
2014
∙
Manisha Patel
Overview of Serogroup B Meningococcal Vaccines and Considerations for Use
2014
∙
ACIP
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register